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Systems/Circuits

Prefrontal Corticotropin-Releasing Factor (CRF) Neurons
Act Locally to Modulate Frontostriatal Cognition and Circuit
Function
X Sofiya Hupalo, Andrea J. Martin, X Rebecca K. Green, X David M. Devilbiss, and Craig W. Berridge
Department of Psychology, University of Wisconsin-Madison, Madison, Wisconsin 53706

The PFC and extended frontostriatal circuitry support higher cognitive processes that guide goal-directed behavior. PFC-dependent
cognitive dysfunction is a core feature of multiple psychiatric disorders. Unfortunately, a major limiting factor in the development of
treatments for PFC cognitive dysfunction is our limited understanding of the neural mechanisms underlying PFC-dependent cognition.
We recently demonstrated that activation of corticotropin-releasing factor (CRF) receptors in the caudal dorsomedial PFC (dmPFC)
impairs higher cognitive function, as measured in a working memory task. Currently, there remains much unknown about CRFdependent regulation of cognition, including the source of CRF for cognition-modulating receptors and the output pathways modulated
by these receptors. To address these issues, the current studies used a viral vector-based approach to chemogenetically activate or inhibit
PFC CRF neurons in working memory-tested male rats. Chemogenetic activation of caudal, but not rostral, dmPFC CRF neurons potently
impaired working memory, whereas inhibition of these neurons improved working memory. Importantly, the cognition-impairing
actions of PFC CRF neurons were dependent on local CRF receptors coupled to protein kinase A. Additional electrophysiological recordings demonstrated that chemogenetic activation of caudal dmPFC CRF neurons elicits a robust degradation of task-related coding
properties of dmPFC pyramidal neurons and, to a lesser extent, medium spiny neurons in the dorsomedial striatum. Collectively, these
results demonstrate that local CRF release within the caudal dmPFC impairs frontostriatal cognitive and circuit function and suggest that
CRF may represent a potential target for treating frontostriatal cognitive dysfunction.
Key words: corticotropin-releasing factor; DREADDs; in vivo electrophysiology; prefrontal cortex; striatum; working memory

Significance Statement
The dorsomedial PFC and its striatal targets play a critical role in higher cognitive function. PFC-dependent cognitive dysfunction
is associated with many psychiatric disorders. Although it has long-been known that corticotropin-releasing factor (CRF) neurons
are prominent within the PFC, their role in cognition has remained unclear. Using a novel chemogenetic viral vector system, the
present studies demonstrate that PFC CRF neurons impair working memory via activation of local PKA-coupled CRF receptors, an
action associated with robust degradation in task-related frontostriatal neuronal coding. Conversely, suppression of constitutive
PFC CRF activity improved working memory. Collectively, these studies provide novel insight into the neurobiology of cognition
and suggest that CRF may represent a novel target for the treatment of cognitive dysfunction.

Introduction
The prefrontal cortex (PFC) supports a diversity of “executive”
cognitive processes that guide goal-directed behavior (Fuster,
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2015). Many psychiatric disorders are associated with dysregulation of PFC-dependent cognition (Cubillo et al., 2010; Liston et
al., 2011). Most drugs used to treat these disorders target catecholamine neurotransmitters. However, there are limitations to
these drugs, including a lack of efficacy across the broader population and, in the case of attention deficit hyperactivity disorder
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(ADHD), the fact that first-line treatments (psychostimulants)
possess risk for abuse (Compton and Volkow, 2006; Setlik et al.,
2009; Berridge and Arnsten, 2015). Thus, there is a need for improved treatments for PFC-dependent cognitive dysfunction.
Unfortunately, the development of alternative treatments is impeded by a scarcity of noncatecholamine targets.
One potential target is corticotropin-releasing factor (CRF). It
has long-been known that CRF neurons and receptors are prominent in the PFC (Swanson et al., 1983; De Souza et al., 1985).
However, despite decades of research on the neurobiology of
subcortical CRF systems, the functional significance of PFC CRF
has been overlooked. We recently demonstrated that CRF receptor activation in the caudal dorsomedial PFC (dmPFC) of rats
disrupts, whereas blockade of these receptors improves, spatial
working memory (Hupalo and Berridge, 2016). These observations indicate that CRF acts in the PFC to regulate higher cognitive function. However, little is currently known about the
neurobiology underlying the cognitive actions of PFC CRF neurotransmission, including fundamental issues, such as the source
of CRF to the PFC and the output pathways impacted by PFC
CRF signaling.
One possible source of CRF for cognition-modulating receptors are local CRF-synthesizing neurons (Olschowka et al., 1982;
Swanson et al., 1983; Merchenthaler, 1984; Charlton et al., 1987;
Lewis et al., 1989). The current study examined the cognitive
actions of PFC CRF neurons using a novel dual-virus chemogenetic approach to bidirectionally manipulate these neurons in
WT rats tested in a working memory task. For this, Credependent “excitatory” (hM3Dq) or “inhibitory” (hM4Di)
designer receptors exclusively activated by designer drugs
(DREADDs) are combined with CRF promoter-specific expression of Cre recombinase. We observed that chemogenetic activation of caudal, but not rostral, dmPFC CRF neurons impaired,
whereas inhibition of caudal dmPFC CRF neurons improved,
working memory. Additional studies demonstrated that the
cognition-impairing effects of caudal dmPFC CRF neurons were
dependent on local CRF receptors coupled to protein kinase A
(PKA) signaling.
The dmPFC projects to the dorsomedial striatum (dmSTR),
forming frontostriatal circuits that support higher cognition
(Voorn et al., 2004; Mailly et al., 2013). Importantly, both nodes
of this circuit are necessary for successful working memory
(Spencer et al., 2012). Within the PFC, subpopulations of pyramidal neurons encode a diversity of information required for
successful goal attainment, as measured in tests of working memory (Curtis and D’Esposito, 2003; Histed et al., 2009; Rigotti et al.,
2013). Limited observations suggest that similar neural coding
mechanisms exist within cognition-related striatal regions
(Schultz and Romo, 1988; Levy et al., 1997; Akhlaghpour et al.,
2016).
The working memory modulatory actions of PFC catecholamines are associated with a robust modulation of taskrelated coding properties of PFC neurons (Arnsten, 2011). The
extent to which these neurophysiological actions are relayed to
the downstream striatum is currently unclear. To determine
whether PFC CRF neurotransmission impacts task-related activity in either the dmPFC or dmSTR, we combined ensemble
single-unit recordings with chemogenetic activation of caudal
dmPFC CRF neurons in working memory-tested animals. Activation of caudal dmPFC CRF neurons robustly degraded taskrelated coding properties of putative pyramidal dmPFC neurons,
with lesser, though significant, effects observed for putative medium spiny neurons in the dmSTR.
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Together, these studies provide the first evidence that PFC
CRF neurons potently disrupt frontostriatal cognitive and circuit
function. Additionally, these observations provide a strong rationale for future research into the behavioral and physiological
actions of PFC CRF neurons, the neural mechanisms subserving
these actions, and the potential clinical relevance of the PFC CRF
system.

Materials and Methods
Animals
Male Sprague Dawley rats (300 –500 g; Charles River) were pair-housed
with enrichment (Nylabone, Bio-Serv) on a 13/11 h light/dark cycle.
Animals used for electrophysiological recordings were singly housed.
Animals were fed ad libitum for 4 –7 d, and food was titrated for
each animal (15–17 g chow/d) to maintain motivation for food reward
while avoiding weight loss. Training/testing was conducted between
0800 and 1600 h 5– 6 d/week. All facilities and procedures were in accordance with National Institutes of Health guidelines and approved by an
Institutional Animal Care and Use Committee.

Working memory training
Training and testing were conducted as previously described (Berridge et
al., 2012b; Hupalo and Berridge, 2016). Briefly, animals were trained to
enter the arm of a T-maze not chosen on the previous trial to receive food
reward (45 mg sucrose pellet/trial, Bio-Serv). Between trials, animals
were placed in a start box at the base of the maze and prevented from
exiting by a gate (see Fig. 2A). Following surgery, animals resumed testing with the introduction of a delay between trials titrated to achieve the
desired performance level. Sessions consisted of 20 trials (one session/d).
For electrophysiology studies, sessions consisted of 30 trials (two sessions/d).

Surgery
Viral infusions. Rats were anesthetized with isoflurane and received a
mixture of two viruses (see Fig. 1A) targeting the rostral (anteroposterior
4.0; lateral ⫾0.8; ventral ⫺2.0 from brain surface) or caudal (anteroposterior 2.6; lateral ⫾0.8; ventral ⫺3.0) dmPFC: AAV8-CRF-Cre (6.5 ⫻
10 13 gc/ml; Vector Biolabs) ⫹ AAV8-hSyn-DIO-hM3Dq-mCherry
(4.6 ⫻ 10 12 gc/ml; Addgene) or AAV8-hSyn-DIO-hM4Di-mCherry
(4 ⫻ 10 12 gc/ml) or AAV8-hSyn-DIO-mCherry (3.1 ⫻ 10 12 gc/ml). The
viral mixture was premixed at a 1:2 ratio of CRF-Cre to DIO-mCherry
and infused into each dmPFC hemisphere at a rate of 0.25 l/min. Injector needles were left in place for 3 min before removal.
Cannulae. A subset of caudal dmPFC CRF-hM3Dq animals was implanted with cannulae (26 gauge) bilaterally over this region (anteroposterior 3.0 –2.4; lateral ⫾0.8; ventral ⫺0.2). Another group of caudal
dmPFC CRF-hM3Dq animals were bilaterally cannulated targeting the
medial septum (MS; anteroposterior 0.5; lateral ⫾0.9 with 4° angle; ventral ⫺0.5).
Electrodes. Additional caudal dmPFC CRF-hM3Dq or control virus
animals were implanted with chronic recording electrodes targeting both
the dmPFC and dmSTR (see Fig. 4A), as previously described (Devilbiss
et al., 2012, 2017). In the PFC, a linear electrode array (8 electrodes/array,
50 m wires, ⬃200 m separation; NB Labs) was implanted into layer V,
oriented rostrocaudally (anteroposterior 3.6 –2.2, lateral ⫾0.75; ventral
⫺3.0). An 8-electrode bundle was unilaterally implanted into the dmSTR
(anteroposterior 0.45; lateral ⫾3.5 with 11.5° angle; ventral ⫺3.6; see
Fig. 5A).
Cannulae and electrodes were secured in place with skull screws and
dental acrylic.

Drugs
CRF (human/rat, Bachem) and the PKA inhibitor, Rp-cAMPs (Tocris
Bioscience), were dissolved in buffered artificial extracellular fluid (147
mM NaCl, 1.3 mM CaCl, 0.9 mM MgCl, 2.5 mM KCl, pH 7.4). D-Phe-CRF
(human/rat, Bachem) and clozapine N-oxide (CNO; NIMH Chemical
Synthesis and Drug Supply Program) were dissolved in 0.9% saline.
Before treatment, CNO was gently warmed to ensure the drug was in
solution.
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Experimental design
Drug treatments. For systemic CNO treatments, animals were injected
subcutaneously (1 ml/kg) 45 min before testing. Bilateral intra-PFC
(3 mm projection) and intra-MS (5.5 mm projection) CNO infusions
were performed with 33-gauge needles using a microprocessorcontrolled pump (Harvard Apparatus) at a rate of 0.25 and 0.125 l/min
for 2 min, respectively. Needles were kept in place for 2 min following
infusions. Smaller infusion volumes (250 nl vs 500 nl) were used for the
MS to minimize drug flow up the needle tract and into the lateral ventricles. Prior studies demonstrate this volume allows selective targeting of
this region with multiple pharmacological manipulations (Berridge et al.,
2012a).
For dual intra-PFC and systemic treatments, animals first received
intra-PFC infusion of D-Phe-CRF, Rp-cAMPs, or vehicle followed by a
subcutaneous CNO or vehicle injection (1 ml/kg). Animals were tested
30 min later.
Working memory testing procedures. Baseline performance levels of
80%–92.5% or 70%– 82.5% were used to detect working memory impairing and improving effects, respectively. Baseline performance was
calculated by averaging an animal’s performance accuracy on the 2 d
immediately before the treatment day. Given performance improves
with repeated testing, delays were increased (10 –30 s) when performance
exceeded the desired range. In this study, no animals exceeded performance criteria past 30 s delays. Animals receiving intratissue infusions
received a mock injection and/or intratissue infusion before the first
treatment.
Histology and immunohistochemistry. Animals were anesthetized and
transcardially perfused with 250 ml chilled heparinized saline (1 unit
heparin/ml 0.9% saline) followed by 450 ml of 4% PFA in 0.01 M PB, pH
7.4. For electrophysiology studies, cathodal 15 A current was first
passed through every electrode for 10 s before perfusion. Brains were
removed, stored in PFA overnight, and taken through graded sucrose
solutions (20%–30% sucrose in 0.1 M PBS, pH 7.4). Electrode or needle
placement was verified in 40-m-thick coronal sections stained with
Neutral Red dye (Sigma-Aldrich).
For immunohistochemical processing of CRF and Fos, sections were
rinsed with 0.01 M PBS and incubated in a blocking agent containing 5%
normal donkey serum in 0.01 M PBS ⫹ 0.1% Triton X-100 at room
temperature for 45 min. Subsequently, the blocking agent was removed,
and sections were incubated in primary guinea pig anti-CRF antibody
(1:4000; catalog #t-5007; Peninsula Labs) or rabbit anti-fos (1:3000; catalog #abe457, EMD Millipore) in the blocking agent overnight at 4°C.
Sections were washed and incubated in secondary donkey anti-guinea
pig AF488 or donkey anti-rabbit AF405 for 1.5 h at room temperature
(Jackson ImmunoResearch Laboratories). Secondary-only controls were
used in all instances. Sections were mounted and coverslipped using
ProLong Diamond Antifade Mountant (Thermo Fisher Scientific). The
primary antibodies used to target CRF and Fos have been extensively
validated using preabsorption and other controls (Das et al., 2007; Rajbhandari et al., 2015; Scharner et al., 2016).
Viral spread and cell counts. The spread of viral expression within the
PFC was determined using 40 m coronal sections. Immunohistochemical and cell counting procedures were used to assess (1) the proportion
of viral-transfected CRF neurons and (2) the extent to which our viral
vector system permitted activation of PFC CRF neurons using Fos immunoreactivity (-ir). Brain sections from animals receiving viral infusions were examined using an Olympus BX51 light and reflected
fluorescence microscope. The spread of virus was mapped throughout
the rostrocaudal and dorsoventral extent of the PFC to ensure that the
majority of viral expression was restricted to one quadrant (rostral vs
caudal dmPFC). For animals receiving intra-PFC viral infusions and
intra-PFC/MS cannulae, alternating sections were Nissl stained to confirm injector needle placement while intervening sections were used to
measure viral spread. Data were included only when histological analyses
verified accurate placement of the reporter protein (mCherry) and minimal tissue damage.
In a subset of animals, single-labeled (CRF-ir/Fos-ir or mCherry) and
double-labeled (CRF-ir/Fos-ir⫹mCherry) neurons were counted in
600⫻ images using a Nikon A1R⫹ confocal microscope. For each sec-

tion, 3 or 4 images were obtained from the main body of viral expression
of each hemisphere. Images were obtained from 3 to 5 sections/animal (4
total animals). Cells were only counted if there was a clear nucleus. The
percentage of double-labeled mCherry neurons was averaged. Cells were
considered double-labeled only when fluorescence was clearly observed
for mCherry (red signal, cytoplasm) and CRF-ir (green signal, cytoplasm) or Fos-ir (UV/blue signal, nucleus) within the same cell.
Electrophysiological recordings in working memory tested rats. On testing days, animals were transported to the recording room and tethered to
a 32-channel commutator and a multichannel electrophysiology acquisition processor (MAP, Plexon). Putative single units in the
dmPFC and dmSTR were isolated using template-matching algorithms to discriminate action potentials. Extracellular action potential
waveforms exhibiting at least a 3:1 signal-to-noise ratio were discriminated using template-matching algorithms. The following criteria ensured that sorted waveforms arose from single neurons: (1) variability of
peak waveform voltage, (2) variability of waveform slope, (3) scattergram
distribution in the first three principal components, and (4) refractory
period (see Fig. 4C). For all recording sessions, neural activity was simultaneously amplified, discriminated, and time stamped as previously described (Devilbiss et al., 2012, 2017).
After spike-sorting, a baseline recording session (30 trials, 10 s delays)
was conducted. One hour later, animals were injected with CNO (3 mg/
kg) or vehicle and 45 min later tested for an additional 30 trial session.
Video recordings (80 frames/s) and IR beam grids time-stamped the
animal’s location in the T-maze (see Fig. 4B). When animals fully entered
a T-maze arm (see Fig. 4A, pink quadrant), either a high- or lowfrequency 0.5 s tone identified correct and incorrect choices, respectively.
Finally, the moment the animal bit on the sucrose pellet (reward) was
time-stamped from video.
Neuron identification and event tuning. For the dmPFC, wide-spiking
(WS), putative glutamatergic, versus narrow-spiking (NS), putative inhibitory cell types were differentiated by quantifying the peak-to-peak
latency of the extracellular action potential waveform (WS ⬎ 200 s; NS,
100 –200 s), as previously described (Povysheva et al., 2006; Mitchell et
al., 2007; Devilbiss et al., 2017). For the dmSTR, medium spiny neurons
(MSNs) and fast-spiking (FS) interneurons were identified using the
peak-to-valley duration (MSN ⬎ 250 s; FS ⬍ 200 s) and firing rate
(MSN ⬍ 8 Hz) (Berke et al., 2004; Kim et al., 2007; Stalnaker et al., 2012).
Distinct subpopulations of dmPFC and dmSTR neurons displayed
excitatory responses to specific T-maze task events, including delay, reward, correct signal, and error signal (see Fig. 4 D, E). Given the relatively
high baseline task accuracy (84.6 ⫾ 1.6%), it was not possible to analyze
error responses of dmPFC or dmSTR neurons. The selective response or
“event-tuning” of a neuron was determined during baseline recordings
from the z score of a neuron’s activity during a particular task interval
versus its overall spiking activity. z scores ⬎0.025 for the delay period and
⬎0.18 for all other task events identified groups of neurons displaying
strong tuning to task events, similar to exemplar responses described by
other laboratories (Fuster and Alexander, 1971; Batuev et al., 1990; Horst
and Laubach, 2013). Lower z score thresholds were used for the delay
interval given it was ⬃10-fold longer in duration than other task intervals. Units displaying z scores between ⫺0.18 and 0.08 (⫺0.045 to 0.01
for the delay) were considered untuned to task events. Units with z scores
ranging between the cutoffs for strongly tuned and untuned neurons
were excluded from analyses.
Consistent with prior studies in working memory tested rats (Hyman
et al., 2010; Devilbiss et al., 2017), we observed no significant differences
in baseline mean spiking rates for left versus right or correct versus incorrect trials among strongly tuned and untuned neurons in either region. Therefore, these task events/conditions were grouped together in
subsequent analyses. To account for any differences in baseline spiking
rates among neurons and experimental cohorts, and to accurately compare the effects of CNO on task-related responses, mean spike rates are
presented as a percentage change from the baseline session.

Statistical analyses
Cognitive testing. A repeated-measures ANOVA analyzed the effect of
drug treatments on performance accuracy. Statistical comparisons be-
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tween drug dose and vehicle were determined using Bonferroni corrected
t tests.
Electrophysiological recordings. The mean spiking rate during each task
interval was determined on a trial-by-trial basis using perievent time
histogram (PETH) analysis. For each neuron, the percentage change in
mean spiking rate from baseline was determined for each task event and
averaged for each neuron category (strongly tuned, untuned). No significant changes in firing rate from baseline were observed in vehicletreated hM3Dq animals or CNO-treated viral controls. Thus, changes in
firing rate were analyzed using group (hM3Dq-CNO, hM3Dq-VEH,
control-CNO) as a between-subject variable in a one-way ANOVA.
Changes in population sizes of strongly tuned and untuned neurons were
calculated using a  2 test. Pairwise comparisons between the three
groups were determined using Bonferroni corrected t tests.

performance comparable with that seen with systemic administration (baseline, 88.6 ⫾ 1.7%; n ⫽ 7, F(1,6) ⫽ 22.4, p ⫽ 0.003). In
contrast, intra-MS CNO infusions had no significant effects on performance (baseline, 85.9 ⫾ 3.3%; F(1,3) ⫽ 0.8, p ⫽ 0.4; Fig. 2Dii).
In contrast to that seen with activation of PFC CRF neurons,
chemogenetic inhibition of caudal dmPFC CRF neurons (CRFCre ⫹ DIO-hM4Di) improved task performance (baseline,
78.1 ⫾ 1.1%) relative to vehicle (baseline, 81.8 ⫾ 1.1%; n ⫽ 8,
F(1,7) ⫽ 15.6, p ⫽ 0.006) or CNO-treated viral controls (baseline,
81.7 ⫾ 2.8%; n ⫽ 7, F(1,14) ⫽ 20.9, p ⬍ 0.001; Fig. 2E). This effect
occurred in the absence of significant effects on maze run time
(vehicle: 2.8 ⫾ 0.3 min; 3 mg/kg CNO: 2.7 ⫾ 0.3 min, F(1,7) ⫽ 0.5,
p ⫽ 0.6; viral controls: 3.9 ⫾ 0.8 min, F(1,14) ⫽ 2.1, p ⫽ 0.1).

Results

Circuit and intracellular signaling mechanisms underlying
the cognitive actions of PFC CRF neurons
Additional studies examined whether CRF neurons in the caudal
dmPFC release CRF locally to impair working memory. Animals
expressing CRF-hM3Dq in this region received infusions of either vehicle or the CRF antagonist, D-Phe-CRF (100 ng/hemisphere) directly into the caudal dmPFC before receiving systemic
CNO at the maximally impairing dose (3 mg/kg; n ⫽ 9). In animals pretreated with intra-PFC vehicle, CNO elicited a robust
working memory impairment (baseline, 86.9 ⫾ 1.8%; F(1,8) ⫽
49.5, p ⬍ 0.001) that was prevented by local D-Phe-CRF infusions
(baseline, 82.6 ⫾ 1.9%; CNO ⫻ antagonist interaction, F(1,8) ⫽
31.4, p ⬍ 0.001; Fig. 3A).
CRF1 receptors are the dominant subtype in the rodent PFC
and may couple to the Gs-PKA intracellular signaling cascade
(Chalmers et al., 1995; Miguel et al., 2014). To examine whether
the cognition-impairing actions of PFC CRF neurons are dependent on local PKA signaling, animals received bilateral infusions
of vehicle or the PKA inhibitor, Rp-cAMPs (20 nM), into the
caudal dmPFC before systemic CNO (3 mg/kg CNO; n ⫽ 5).
Rp-cAMPs alone had no significant effects on task performance
(Fig. 3B; baseline, 85.6 ⫾ 1.2%; F(1,4) ⫽ 1.4, p ⫽ 0.3). In animals
pretreated with intra-PFC vehicle, CNO impaired task performance (baseline, 88.5 ⫾ 1.3%; F(1,4) ⫽ 29.4, p ⫽ 0.005), whereas
intra-PFC Rp-cAMPs pretreatment completely blocked this effect (baseline, 85.6 ⫾ 2.1%; CNO ⫻ Rp-cAMPs interaction;
F(1,4) ⫽ 27.2, p ⫽ 0.01; Fig. 3B).

Chemogenetic targeting of CRF neurons
To assess the working memory actions of PFC CRF neurons,
“excitatory” (hM3Dq) or “inhibitory” (hM4Di) DREADDs were
infused into the caudal or rostral dmPFC (Fig. 1A). An additional
group received a control virus mixture lacking a DREADD transgene (CRF-Cre ⫹ DIO-mCherry). Robust reporter protein expression was observed within 3 weeks (Fig. 1B). Viral expression
was limited to a radius of ⬃500 m, filling the majority of either
the rostral or caudal dmPFC with minimal spread into the ventromedial PFC or adjacent dmPFC hemifields (Fig. 2Bi,Ci). The
viral mixture transfected CRF neurons efficiently: 94 ⫾ 5% of
mCherry neurons colocalized with CRF-ir (n ⫽ 354 cells, 4 animals; Fig. 1C). Importantly, mCherry-positive cells lacking
CRF-ir were not observed.
To assess whether the DREADD agonist, CNO, activates
hM3Dq-expressing PFC CRF neurons, we examined Fos-ir in
hM3Dq (n ⫽ 4) or viral control animals (n ⫽ 3) treated with 3
mg/kg CNO in the home-cage (highest dose used in subsequent
studies). In hM3Dq animals, CNO elicited Fos-ir in 79 ⫾ 0.6% of
mCherry neurons (n ⫽ 347; Fig. 1Di). In contrast, no Fos-ir was
observed in mCherry neurons within the dmPFC of viral controls
(Fig. 1Dii).
Working memory actions of PFC CRF neurons
Chemogenetic activation of caudal dmPFC CRF neurons (CRFCre ⫹ DIO-hM3Dq, n ⫽ 7) dose-dependently impaired working
memory performance (baseline, 83.9 ⫾ 2.1%) relative to vehicle
(baseline, 80.7 ⫾ 1.7%; F(1,6) ⫽ 28.6, p ⫽ 0.002) and CNOtreated viral controls (baseline, 81.7 ⫾ 2.8%; n ⫽ 7, F(1,13) ⫽ 35.0,
p ⬍ 0.001; Fig. 2Bii). This occurred in the absence of significant
changes in run time (vehicle: 3.6 ⫾ 1.0 min; 3 mg/kg CNO: 3.8 ⫾
0.5 min, F(1,6) ⫽ 1.1, p ⫽ 0.4; viral controls: 3.9 ⫾ 1.0 min,
F(1,13) ⫽ 1.5, p ⫽ 0.3). In contrast, chemogenetic activation of
rostral dmPFC CRF neurons (n ⫽ 6) had no significant effects on
performance (baseline, 86.7 ⫾ 1.7%) relative to vehicle (baseline,
84.2 ⫾ 2.1%; F(1,5) ⫽ 0.9, p ⫽ 0.39) or CNO-treated viral controls
(n ⫽ 7; F(1,12) ⫽ 1.0, p ⫽ 0.3; Fig. 2Cii).
In general, mCherry expression was not observed outside the
targeted region of the PFC. The one exception to this was in
⬃30% of animals receiving viral infusions in the caudal, but not
rostral dmPFC, retrograde mCherry labeling of cell bodies was
observed in the MS (Fig. 2Di), a region known to project to the
PFC (Senut et al., 1989). To determine whether activation of MS
CRF neurons could have contributed to the cognition-impairing
effects of systemic CNO, a subset of animals containing mCherry
in the MS (confirmed postmortem; n ⫽ 4) were infused with
CNO directly into the MS or caudal dmPFC. In these animals,
CNO infusions (0.5 mM) into the caudal dmPFC impaired task

Effects of PFC CRF neuronal activation on task-related
activity across the frontostriatal circuit
To assess the effects of caudal dmPFC CRF neuronal activation
on the coding properties of neurons within dorsomedial frontostriatal circuitry, animals were implanted with chronic recording
electrodes in the dmPFC and dmSTR following intracaudal
dmPFC infusion of CRF-hM3Dq (n ⫽ 5) or viral vector control
animals (n ⫽ 3) (Fig. 4). Animals were tested for a 30 trial baseline
session and a second 30 trial session following treatment with
vehicle or CNO.
Baseline neuronal response properties
Across all animals, we isolated a total of 420 dmPFC neurons
(most within dorsal prelimbic PFC), 96% classified as WS and 4%
as NS. Due to the low number of NS dmPFC neurons isolated,
these neurons were not analyzed further. Under baseline conditions, 25% of dmPFC WS, putative pyramidal, neurons were classified as being strongly tuned to the delay interval, whereas 10%
were strongly tuned to reward. Interestingly, dmPFC WS neurons were relatively insensitive to the correct signal tone and thus
were not analyzed further. A larger proportion of dmPFC WS

2084 • J. Neurosci., March 13, 2019 • 39(11):2080 –2090

Hupalo et al. • PFC CRF and Frontostriatal Cognitive Function

Figure 1. Chemogenetic approach. A, Schematic depicting dual viral system to activate (CRF-Cre ⫹ hSyn-DIO-hM3Dq) or inhibit (CRF-Cre ⫹ hSyn-DIO-hM4Di) CRF neurons in the PFC. B,
Photomicrograph depicting mCherry expression in the caudal dmPFC from a CRF-hM3Dq-treated animal. Scale bar, 200 m. cc, Corpus callosum. C, Top, Collapsed 30 m z stack from inset in B,
demonstrating mCherry colocalization with CRF-ir cells. Scale bar, 30 m. Bottom, Inset from above, rotated at various angles. Scale bar, 10 m. Di, CNO elicits an excitatory influence in PFC CRF neurons as
measured by Fos-ir in mCherry neurons of CNO-treated CRF-hM3Dq animals. Dii, Absence of Fos-ir in the PFC of CNO-treated viral controls (mCherry ⫹ CNO; CRF-Cre hSyn-DIO-mCherry). Scale bar, 10 m.

neurons was classified as being insensitive (“untuned”) to task
events (delay, 39%; reward, 53%).
Within the dmSTR, we isolated a total of 255 neurons, 88%
classified as MSN, 9% as FS, and 3% unclassified. Given the rel-

atively small number of FS neurons, only MSNs were included in
subsequent analyses. dmSTR MSN neurons also displayed strong
delay-related (30%) and reward-related (16%) activity. In contrast to the dmPFC, a robust subpopulation of MSNs exhibited
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Figure 2. CRF neurons in the caudal, but not rostral, dmPFC modulate working memory. A, T-maze schematic. Bi, Schematics depict hM3Dq viral spread in the caudal dmPFC (anteroposterior
3.2–2.2) from all animals tested. Bii, CNO dose-dependently impairs task performance relative to vehicle (n ⫽ 7) and CNO-treated viral control animals (n ⫽ 7; control 3 mg/kg). Ci, hM3Dq viral
spread in the rostral dmPFC (anteroposterior 4.2–3.2). Cii, Chemogenetic activation of CRF neurons in the rostral dmPFC has no significant effects on task performance relative to vehicle (n ⫽ 6) and
viral controls (n ⫽ 7). Di, Left, Retrograde mCherry cell body labeling observed in the MS in ⬃30% of animals. Right, Schematics representing intra-MS infusion sites (n ⫽ 4). Dii, When infused into
the PFC, 0.5 mM CNO robustly impairs task performance (n ⫽ 7), while having no effects on performance when infused into the MS (n ⫽ 4). E, Chemogenetic suppression of CRF neurons in the caudal
dmPFC improves task performance relative to vehicle (n ⫽ 8) and CNO-treated viral controls (n ⫽ 7). Results are mean ⫾ SEM percentage change in accuracy relative to baseline. *p ⬍ 0.05 versus
vehicle. ⫹p ⬍ 0.001 versus viral controls. **p ⬍ 0.01 versus vehicle. ***p ⬍ 0.001 versus vehicle. ⫹⫹⫹p ⬍ 0.001 versus viral controls.

24, 54% reduction) relative to vehicle or
CNO-treated viral controls (hM3DqVEH: n ⫽ 25, ⫺0.6%; control-CNO: n ⫽
54, 0.1%; Fig. 5C). Activation of PFC CRF
neurons significantly diminished the population size of strongly tuned delay neurons by 75% relative to hM3Dq-VEH
(⫺8%) and control-CNO (⫺30%)
groups ( 2 ⫽ 6.3, p ⫽ 0.04; Fig. 5C). PFC
CRF neuronal activation also significantly
reduced reward-related activity of WS
neurons (F(2,39) ⫽ 3.1, p ⫽ 0.05, n ⫽ 16,
⫺29.1%) relative to vehicle (n ⫽ 15,
⫺0.9%) and viral controls (n ⫽ 11, 2.6%),
while not significantly affecting the popuFigure 3. Working memory actions of caudal dmPFC CRF neurons are dependent on local CRF receptors coupled to PKA.
of strongly tuned reward neuA, Intra-PFC infusion of the nonselective CRF antagonist D-Phe-CRF (100 ng/hemisphere) blocks the working memory-impairing lation size
2

rons
(
⫽
0.1, p ⫽ 0.9; hM3Dq-CNO,
effects of chemogenetic activation of caudal dmPFC CRF neurons (3 mg/kg CNO; n ⫽ 9). B, Intra-PFC infusion of the PKA inhibitor
Rp-cAMPs (20 nM/hemisphere) also blocks the working memory-impairing effects of 3 mg/kg CNO (n ⫽ 5). Results are mean ⫾ ⫺19%; hM3Dq-VEH, ⫺13%; controlSEM percentage change in accuracy relative to baseline. *p ⬍ 0.05. **p ⬍ 0.01. ***p ⬍ 0.001.
CNO, ⫺27%; Fig. 5C).
As shown in Figure 5D, PFC CRF neuronal activation had no significant effects
prominent and punctate excitatory responses to the correct signal
on the larger population of WS neurons that were untuned to
tone (21%). A large proportion of MSNs were untuned to delay
either delay (spiking: F(2,157) ⫽ 1.1, p ⫽ 0.3; population size:  2 ⫽
(41%), reward (72%), and correct signal (64%).
0.7, p ⫽ 0.7) or reward (spiking: F(2,213) ⫽ 0.23, p ⫽ 0.8; populaEffects of caudal dmPFC CRF neuronal activation on task-related
tion size:  2 ⫽ 2.04, p ⫽ 0.4).
activity in the dmPFC
Vehicle treatment of hM3Dq animals (n ⫽ 4) or CNO treatment
PFC CRF neuronal activation elicits a weaker degradation of
(3 mg/kg) of viral controls (n ⫽ 3) did not significantly affect
task-related activity in the dmSTR
Chemogenetic activation of PFC CRF neurons robustly diminworking memory (hM3Dq-VEH: baseline, 84.3 ⫾ 1.9%; p ⫽
ished the population size of delay-tuned MSNs (⫺75%) relative
0.14; control-CNO: baseline, 84.1 ⫾ 2.2%; p ⫽ 0.16; Fig. 5B). In
to vehicle (⫺7%) and CNO-treated viral controls (14%;  2 ⫽ 5.7,
hM3Dq animals (n ⫽ 5), CNO significantly impaired task perp ⫽ 0.05; Fig. 6A). This was accompanied by a nonsignificant
formance (baseline, 85.4 ⫾ 2.3%; p ⫽ 0.0001; Fig. 5B). This was
associated with a robust suppression of task-related activity of
trend for reduction in delay-related activity (F(2,65) ⫽ 1.3, p ⫽ 0.2,
delay-tuned dmPFC WS neurons (F(2,100) ⫽ 22.3, p ⬍ 0.001, n ⫽
n ⫽ 12, ⫺18.4%) relative to vehicle (⫺3.6%, n ⫽ 28) and CNO-
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Figure 4. Frontostriatal recordings in working memory-tested rats. A, T-maze schematic illustrating task events, including delay, two distinct auditory tones serving as outcome-related signals
on correct versus error trials, and sugar reward. B, Animal position is tracked using video recordings and infrared beams. C, Top, Action potential waveforms of 4 discriminated WS dmPFC neurons.
Bottom, Waveforms from these units exhibit separable clusters in 3D-principal component space. D, Exemplar rasters (top) and PETHs (bottom) of WS dmPFC neurons exhibiting punctate excitatory
responses during T-maze events. Shaded areas of PETHs represent duration of interval. Spiking rates were calculated for 100 ms time bins. E, Exemplar rasters and PETHs of putative MSNs within the
dmSTR displaying strong task tuning.

treated viral controls (n ⫽ 28, 1.0%; Fig. 6A). For reward-tuned
MSNs, PFC CRF neuronal activation did not significantly affect
task-related activity (⫺21%, F(2,33) ⫽ 1.2, p ⫽ 0.3, n ⫽ 9; VEH,
0%, n ⫽ 20; CNO-treated controls, 2.2%, n ⫽ 19), or population
size ( 2 ⫽ 0.01, p ⫽ 0.9; Fig. 6A). MSNs strongly tuned to the
correct signal were insensitive to CNO or vehicle across all groups
(spiking: F(2,45) ⫽ 0.03, p ⫽ 0.9; population size:  2 ⫽ 0.6, p ⫽
0.7), as were MSNs untuned to delay (spiking: F(2,89) ⫽ 0.5, p ⫽
0.6; population size:  2 ⫽ 0.6, p ⫽ 0.7), reward (spiking:
F(2,158) ⫽ 0.06, p ⫽ 0.9; population size:  2 ⫽ 0.9, p ⫽ 0.6), and
correct signal (spiking: F(2,140) ⫽ 0.1, p ⫽ 0.9; population size:
 2 ⫽ 1.1, p ⫽ 0.5; Fig. 6B).

Discussion
Both the PFC and CRF have long been implicated in psychopathology associated with cognitive impairment. Given this, it is
surprising that the cognitive actions of CRF neurotransmission in
the PFC have been largely overlooked. The current studies provide the first evidence that CRF neurons in the caudal dmPFC are
constitutively active under working memory testing conditions
and act to impair working memory via local PKA-coupled CRF
receptors. Additionally, these studies demonstrate that the
cognition-impairing action of CRF neurotransmission in the
caudal dmPFC is associated with a robust degradation of delayand reward-related activity within the dmPFC and, to a lesser
extent, in the dmSTR. Collectively, these observations provide
novel insight into the neurobiology of frontostriatal-dependent
cognition and suggest that CRF may represent a novel target for
the treatment of PFC/frontostriatal-dependent cognitive dysfunction.

Topography of CRF actions within the dmPFC
The cognitive actions of PFC CRF neurons were topographically
organized, being limited to the caudal portion of the dmPFC.
This is consistent with a well-described functional topography of
the rodent medial PFC dorsoventrally (Voorn et al., 2004; Gabbott et al., 2005) and rostrocaudally (Alsene et al., 2011; Hupalo
and Berridge, 2016). The neural bases for the topography associated with the cognitive actions of PFC CRF are currently
unknown. Given CRF neurons and receptors are present
throughout the medial PFC (Swanson et al., 1983; De Souza et al.,
1985), this topography does not appear to arise from differential
neuronal and/or receptor distribution. Instead, this may reflect a
topographical organization in the projection patterns of PFC
neurons. Recent studies indicate that CRF-synthesizing and CRF
receptor-expressing neurons in the rodent PFC represent distinct
neuronal populations (Uribe-Mariño et al., 2016). Moreover, at
least some of these CRF receptor-expressing neurons are pyramidal neurons (Gallopin et al., 2006). Thus, the restriction of the
cognitive effects of CRF neurotransmission to the caudal dmPFC
may reflect unique projection patterns of CRF receptorexpressing pyramidal neurons from this region. Consistent with
this, extensive evidence demonstrates differing efferent projection targets across dorsal versus ventral PFC subfields (Sesack et
al., 1989; Heidbreder and Groenewegen, 2003; Gabbott et al.,
2005). The topographical organization of rostral versus caudal
PFC projections has been less intensively studied. However, limited observations indicate the rostral medial PFC extends denser
projections to the rostroventral and dmSTR, whereas the caudal
medial PFC more strongly innervates the caudal ventral striatum
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Figure 5. Chemogenetic activation of CRF neurons in the caudal dmPFC degrades delay and reward signaling in WS dmPFC neurons. A, Left, Schematics depicting CRF-hM3Dq expression in the
caudal dmPFC and electrode placements in the dmPFC and dmSTR. Right, 4⫻ photomicrographs depicting placement of one electrode in layer V of the dmPFC and three electrodes in the dmSTR.
Scale bar, 250 m. B, In recorded animals, CNO impaired task performance in the hM3Dq group (5 animals, 7 recording sessions), but not in vehicle (4 animals, 10 sessions) or CNO-treated viral
controls (3 animals, 10 recording sessions). C, Left, Exemplar rasters/PETHs demonstrating task-related activity of strongly tuned delay (top) and reward (bottom) WS neurons under baseline and
CNO conditions (delay, 10 s; reward, 1 s). Middle, CNO-induced activation of dmPFC CRF neurons robustly suppressed task-related activity of strongly tuned delay (n ⫽ 24) and reward (n ⫽ 16), WS
neurons relative to vehicle (delay, n ⫽ 25; reward, n ⫽ 15), and CNO-treated viral controls (delay, n ⫽ 54; reward, n ⫽ 11). Right, PFC CRF neuronal activation diminished the population size of
strongly tuned delay (top), but not reward (bottom) neurons. D, Left, Exemplar rasters/PETHs of a WS neuron untuned to delay (top) and reward (bottom) under baseline and CNO conditions. CNO
had no significant effects on task-related activity (middle) or population sizes (right) of these neurons in hM3Dq animals (delay, n ⫽ 55; reward, n ⫽ 65), relative to vehicle (delay, n ⫽
40; reward, n ⫽ 59), and viral controls (delay, n ⫽ 64; reward, n ⫽ 92). *p ⬍ 0.05 versus control-CNO. ⴙp ⬍ 0.05 versus hM3Dq-SAL. ***p ⬍ 0.001 versus control-CNO. ⫹⫹⫹p ⬍
0.001 versus hM3Dq-SAL.

and mediodorsal thalamic nucleus (Sesack et al., 1989; Gorelova
and Yang, 1997). The neural basis for the topography associated
with the cognitive actions of PFC CRF neurotransmission is an
important area for future studies.
Neurocircuitry underlying the cognitive actions of PFC
CRF neurons
Limited evidence indicates at least some PFC CRF neurons are
GABAergic interneurons (Mohila and Onn, 2005; Helmeke et al.,
2008). Consistent with this, recent immunohistochemical studies
in our laboratory indicate that ⬃15% of CRF neurons are immu-

noreactive for the GABAergic marker, GAD67, with the remaining 85% displaying immunoreactivity for the glutamatergic marker,
CaMKII␣. The observation that CRF acts locally in the PFC to impair working memory could implicate GABAergic CRF interneurons in the cognitive effects of our chemogenetic manipulations.
However, the fact that PFC CRF neuronal activation had no effects
on the broader population of neurons not displaying task-related
activity indicates that PFC CRF signaling does not generally increase
inhibitory tone within the dmPFC. Ongoing studies in our laboratory are investigating the potential contribution of distinct PFC CRF
neuronal subpopulations to working memory.
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Figure 6. Effects of PFC CRF neuronal activation on task-related activity of dmSTR MSNs. A, Left, Exemplar rasters/PETHs demonstrating task-related activity of strongly tuned delay (top) and
reward (bottom) MSNs under baseline and CNO conditions. Middle, CNO elicited a trend for suppression of task-related activity of strongly tuned delay (n ⫽ 12) and reward MSNs (n ⫽ 9) in hM3Dq
animals that was not observed with vehicle (delay, n ⫽ 28; reward, n ⫽ 15) or CNO-treated viral controls (delay, n ⫽ 28; reward, n ⫽ 12). Right, PFC CRF neuronal activation diminished the
population size of strongly tuned delay (top), but not reward (bottom), MSNs. B, Left, Exemplar rasters/PETHs of MSNs untuned to delay (top) and reward (bottom) MSNs. CNO elicited no significant
effects on task-related activity (middle) or the population size (right) of untuned MSNs in hM3Dq animals (delay, n ⫽ 27; reward, n ⫽ 35), vehicle-treated hM3Dq animals (delay, n ⫽ 26; reward,
n ⫽ 65), or CNO-treated viral controls (delay, n ⫽ 39; reward, n ⫽ 61). *p ⬍ 0.05 versus control-CNO. ⴙp ⬍ 0.05 versus hM3Dq-SAL.

Chemogenetic activation of caudal dmPFC CRF neurons robustly suppressed delay-related activity of dmPFC neurons. This
was accompanied by a dramatic decrease in the population size of
WS neurons identified as strongly tuned to delay. A weaker,
though significant, suppression of reward-related activity was
also observed. Consistent with the weaker nature of this effect, we
did not observe a significant reduction in the population size of
reward-tuned PFC neurons. The neural mechanisms underlying
the preferential actions of PFC CRF neurotransmission on delayrelated activity remain to be determined. In the downstream
dmSTR, activation of PFC CRF neurons strongly reduced the
population of delayed-tuned neurons, but elicited weaker and
nonsignificant reductions in the firing rate of delay- and rewardtuned MSNs. Combined, these observations indicate that caudal
dmPFC CRF neurons weaken task-related coding broadly, but
differentially, within frontostriatal circuitry.
Consistent with prior studies, we observed no mCherry fibers
in the dmSTR, suggesting that PFC CRF neurons may not directly
innervate the dmSTR (Swanson et al., 1983; Merchenthaler,
1984). Nonetheless, PFC CRF neuronal activation weakened
task-related neuronal coding in the dmSTR. It is possible that
delay-related activity of dmSTR neurons is driven, at least in part,
by excitatory projections from delay and reward-tuned pyrami-

dal neurons in the dmPFC. Thus, CRF-dependent reductions in
excitatory signaling from the dmPFC to the dmSTR may contribute to a weakening of task-related activity in the dmSTR. The
weaker effects observed in the dmSTR, relative to the dmPFC,
could reflect the fact that task-related activity of MSNs is not
solely driven by caudal dmPFC delay-tuned neurons. Indeed,
both the rostral and caudal aspects of the dmPFC are known to
project to the dmSTR region recorded from in the current studies
(Spencer et al., 2012). Thus, neurons in the rostral dmPFC may
well contribute to task-related coding in the dmSTR. The precise
neural circuitry by which PFC CRF signaling modulates downstream striatal targets remains a topic of future studies.
Translational relevance
PFC cognitive dysfunction is associated with a variety of behavioral disorders, including ADHD, depression, schizophrenia, and
addiction. The fact that CRF acts in the PFC to modulate higher
cognitive function could implicate CRF in one or more of these
disorders and/or suggest that drugs interfering with CRF neurotransmission may have therapeutic potential for the treatment
of PFC-dependent cognitive dysfunction. Additionally, the current observations suggest that the cognition-enhancing actions of
caudal dmCRF neuronal suppression mimic those seen with all
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FDA-approved drugs for ADHD (Spencer et al., 2015). Thus,
CRF may represent a novel target for the development of pharmacological treatments for this disorder. Beyond these clinical
conditions, the cognitive and neurophysiological actions of PFC
CRF neuronal activation are similar to those seen with stress and
stress-related disorders (Birnbaum et al., 1999; Arnsten, 2009;
Devilbiss et al., 2017). Evidence suggests acute stress increases
levels of both CRF and CRF1 receptor mRNA in the PFC (Meng
et al., 2011; Uribe-Mariño et al., 2016). Additionally, viralmediated deletion of CRF1 receptors prevented acute stressinduced impairment in reversal learning (Uribe-Mariño et al.,
2016). Collectively, these observations suggest the hypothesis
that stress-related cognitive impairment involves increased CRF
neurotransmission in the PFC.
While CRF neurotransmission in the PFC may contribute to
stress-related cognitive impairment, in the current studies, animals were highly habituated and motivated to engage in cognitive
testing and displayed relatively high baseline performance accuracy. Thus, the cognition-enhancing actions of CRF neuronal
suppression are unlikely to reflect solely an “anti-stress” effect.
Instead, these results suggest that PFC CRF neurons are active
across a range of conditions associated with higher arousal and
motivational states, both stressful and nonstressful (Merali et al.,
2004). The broader behavioral actions of CRF neurotransmission
in the PFC and the translational relevance of these actions are
important topics for future research.
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